<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(9)</volume><submitter>De Meyer J</submitter><pubmed_abstract>The use of saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sparks debate due to presumed lower sensitivity and lack of standardization. Our aim was to evaluate the performance characteristics of (i) saliva collected by the ORAcollect&lt;sup>TM&lt;/sup> device as a matrix for SARS-CoV-2 reverse-transcriptase polymerase chain reaction (RT-PCR), and (ii) 2 saliva rapid antigen tests (AgRDT). From 342 ambulatory individuals, both a nasopharyngeal swab and saliva sample via ORAcollect&lt;sup>TM&lt;/sup> were obtained for a SARS-CoV-2 RT-PCR test. Furthermore, 54 and 123 additionally performed the V-Chek&lt;sup>TM&lt;/sup> or Whistling&lt;sup>TM&lt;/sup> saliva AgRDT. In total, 35% of individuals screened positive for SARS-CoV-2 via nasopharyngeal swab. Saliva, as a matrix for t</pubmed_abstract><journal>Viruses</journal><pagination>1931</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9502549</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Evaluation of Saliva as a Matrix for RT-PCR Analysis and Two Rapid Antigen Tests for the Detection of SARS-CoV-2.</pubmed_title><pmcid>PMC9502549</pmcid><pubmed_authors>De Meyer J</pubmed_authors><pubmed_authors>Goris H</pubmed_authors><pubmed_authors>Jansens H</pubmed_authors><pubmed_authors>Hans G</pubmed_authors><pubmed_authors>Goossens H</pubmed_authors><pubmed_authors>Mortele O</pubmed_authors><pubmed_authors>Vandamme S</pubmed_authors><pubmed_authors>Matheeussen V</pubmed_authors><pubmed_authors>Spiessens A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluation of Saliva as a Matrix for RT-PCR Analysis and Two Rapid Antigen Tests for the Detection of SARS-CoV-2.</name><description>The use of saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sparks debate due to presumed lower sensitivity and lack of standardization. Our aim was to evaluate the performance characteristics of (i) saliva collected by the ORAcollect&lt;sup>TM&lt;/sup> device as a matrix for SARS-CoV-2 reverse-transcriptase polymerase chain reaction (RT-PCR), and (ii) 2 saliva rapid antigen tests (AgRDT). From 342 ambulatory individuals, both a nasopharyngeal swab and saliva sample via ORAcollect&lt;sup>TM&lt;/sup> were obtained for a SARS-CoV-2 RT-PCR test. Furthermore, 54 and 123 additionally performed the V-Chek&lt;sup>TM&lt;/sup> or Whistling&lt;sup>TM&lt;/sup> saliva AgRDT. In total, 35% of individuals screened positive for SARS-CoV-2 via nasopharyngeal swab. Saliva, as a matrix for t</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-27T02:02:53.573Z</modification><creation>2025-04-06T18:25:52.951Z</creation></dates><accession>S-EPMC9502549</accession><cross_references><pubmed>36146737</pubmed><doi>10.3390/v14091931</doi></cross_references></HashMap>